TickerFacts.

ENDRA Life Sciences Inc. (NDRA): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2020-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$0
Year ended 2020-12-31
$172.8K2017-12-31: $172.8K2018-12-31: $02019-12-31: $02020-12-31: $0$0
2017-12-31 Cost of Revenue (USD) 2020-12-31
Period endedCost of RevenueChange YoYSource filing
2020-12-31$0n/a2021-03-25, From 2020-01-01
2019-12-31$0n/a2021-03-25, From 2019-01-01
2018-12-31$0-100.0%2020-03-26, From 2018-01-01
2017-12-31$172.8Kn/a2019-03-11, From 2017-01-01